Cargando…
Retracted: Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356424/ https://www.ncbi.nlm.nih.gov/pubmed/37476810 http://dx.doi.org/10.1155/2023/9834612 |
| _version_ | 1785075270662750208 |
|---|---|
| author | Healthcare Engineering, Journal of |
| author_facet | Healthcare Engineering, Journal of |
| author_sort | Healthcare Engineering, Journal of |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10356424 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103564242023-07-20 Retracted: Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125 Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-07-12 /pmc/articles/PMC10356424/ /pubmed/37476810 http://dx.doi.org/10.1155/2023/9834612 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Healthcare Engineering, Journal of Retracted: Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125 |
| title | Retracted: Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125 |
| title_full | Retracted: Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125 |
| title_fullStr | Retracted: Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125 |
| title_full_unstemmed | Retracted: Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125 |
| title_short | Retracted: Clinical Efficacy of Yiqi Yangyin Decoction Combined with Docetaxel on Advanced Ovarian Cancer and the Effect on the Levels of Serum Markers VEGF, HE4, and CA125 |
| title_sort | retracted: clinical efficacy of yiqi yangyin decoction combined with docetaxel on advanced ovarian cancer and the effect on the levels of serum markers vegf, he4, and ca125 |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356424/ https://www.ncbi.nlm.nih.gov/pubmed/37476810 http://dx.doi.org/10.1155/2023/9834612 |
| work_keys_str_mv | AT healthcareengineeringjournalof retractedclinicalefficacyofyiqiyangyindecoctioncombinedwithdocetaxelonadvancedovariancancerandtheeffectonthelevelsofserummarkersvegfhe4andca125 |